| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/01/2008 | US7393869 3-[5-(4-methylbenzylidene)-4-oxo-2-thioxothiazolidin-3-yl]-N-(4-sulfamoylphenyl)-propionamide; compounds are protein tyrosine phosphatse inhibitors; antiinflmmatory, anticarcinogenic agents |
| 07/01/2008 | US7393861 Derivatives of 4-aminopiperidine and their use as a medicament |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393857 Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393828 to be used in pharmaceutical delivery vehicles for controlled and/or localized release of therapeutic molecules (e.g., small molecules, peptides, proteins or other macromolecules). |
| 07/01/2008 | US7393824 Methods of peptide preparation |
| 07/01/2008 | US7393823 isolated polypeptide, glycosylated polypeptide and monoclonal antibody and their combinations; binds to the extracellular domain of EGF receptor |
| 07/01/2008 | US7393657 Diagnosis and treatment of cancer: I |
| 07/01/2008 | US7393551 Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 07/01/2008 | US7393531 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 07/01/2008 | US7393527 Method for limiting the growth of cancer cells using an attenuated measles virus |
| 07/01/2008 | US7393526 Systemic gene delivery vehicles for the treatment of tumors |
| 07/01/2008 | US7393524 Baculovirus vectors comprising a capsid polypeptide fused to a GNRH polypeptide |
| 07/01/2008 | US7393478 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/29/2008 | CA2601963A1 Method of enriching glucoraphanin in radish seed preparations |
| 06/26/2008 | WO2008077077A2 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 06/26/2008 | WO2008076964A1 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of atp production |
| 06/26/2008 | WO2008076949A2 Quinazoline derivatives and methods of treatment |
| 06/26/2008 | WO2008076943A1 Compositions and methods for treatment of cancer |
| 06/26/2008 | WO2008076778A1 4-amino-1h-pyrimidin-2-one based compounds, compositions comprising them, and methods of their use |
| 06/26/2008 | WO2008076705A1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
| 06/26/2008 | WO2008076704A1 Imidazolidinonyl aminopyrimidine compounds for the treatment' of cancer |
| 06/26/2008 | WO2008076415A1 Methods of using mek inhibitors |
| 06/26/2008 | WO2008076379A2 Human antibodies to human delta like ligand 4 |
| 06/26/2008 | WO2008076373A1 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 06/26/2008 | WO2008076278A2 Methods of cancer treatment with igf1r inhibitors |
| 06/26/2008 | WO2008076143A1 Combination of igfr inhibitor and anti-cancer agent |
| 06/26/2008 | WO2008076127A1 Inhibitory polynucleotide compositions and methods for treating cancer |
| 06/26/2008 | WO2008075866A1 A composition comprising the processed extract of panax quinquefolium l. for the prevention and treatment of cancer |
| 06/26/2008 | WO2008075713A1 Marker for diagnosis of cancer, and target molecule for therapy |
| 06/26/2008 | WO2008075349A1 Therapeutic methods using a thymus peptide |
| 06/26/2008 | WO2008075342A1 Treatment of lung cancer |
| 06/26/2008 | WO2008075330A1 Method for administration of pegylated liposomal doxorubicin |
| 06/26/2008 | WO2008075196A1 Benzimidazole derivatives |
| 06/26/2008 | WO2008075110A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 06/26/2008 | WO2008075109A1 Substituted piperidines having protein kinase inhibiting activity |
| 06/26/2008 | WO2008075104A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
| 06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
| 06/26/2008 | WO2008075048A2 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments |
| 06/26/2008 | WO2008075042A1 Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent |
| 06/26/2008 | WO2008075007A1 Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents |
| 06/26/2008 | WO2008074997A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 06/26/2008 | WO2008074872A1 Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition |
| 06/26/2008 | WO2008074865A1 Dimeric prolactin receptor ligands |
| 06/26/2008 | WO2008074788A1 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 06/26/2008 | WO2008074749A1 Indazole derivatives as kinase inhibitors for the treatment of cancer |
| 06/26/2008 | WO2008074572A1 Use of tri-substituted glycerol compounds for the treatment of hematological malignancies |
| 06/26/2008 | WO2008074515A1 Novel hetaryl-phenylene-diamine pyrimidine as protein kinase inhibitors |
| 06/26/2008 | WO2008074253A1 Pyridazinoindole derivatives, their preparation and therapy use |
| 06/26/2008 | WO2008074230A1 Interferon alpha mutant and its polyethylene glycol derivative |
| 06/26/2008 | WO2008074189A1 A recombinant adenovirus comprising recombinant khp50 gene and preparation method and uses thereof |
| 06/26/2008 | WO2008074132A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/26/2008 | WO2008074130A1 Anti-tumour immunity induction by a non-replicatmg adenovirus encoding tap-1 |
| 06/26/2008 | WO2008074091A1 Radioprotector compounds and related methods |
| 06/26/2008 | WO2008074078A1 Selectively deliverable isatin-based cytotoxic agents |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |
| 06/26/2008 | WO2008058126A3 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
| 06/26/2008 | WO2008057512A3 Imidazopyrazines as protein kinase inhibitors |
| 06/26/2008 | WO2008046228A8 Compounds for stimulating p-glycoprotein function and uses thereof |
| 06/26/2008 | WO2008041514A9 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 06/26/2008 | WO2008034644A3 Process for making anastrozole |
| 06/26/2008 | WO2008027445A3 Combination with bis(thiohydrazide amides) for treating cancer |
| 06/26/2008 | WO2008009639A3 New indications for direct thrombin inhibitors |
| 06/26/2008 | WO2008007290A3 Core-shell nanoparticles for thearapy and imaging purposes |
| 06/26/2008 | WO2007118335A9 Hepoxilin analog enantiomers |
| 06/26/2008 | WO2007101676A3 Treatment, diagnosis and imaging of mantle cell lymphoma |
| 06/26/2008 | WO2007075605A3 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production |
| 06/26/2008 | US20080153926 Methods and compositions for modulating mitochondrial alderhyde dehydrogenase-2 |
| 06/26/2008 | US20080153907 Pharmaceutical Composition for the Treatment of Cancer Comprising Lhm-Ra Complex |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153898 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 06/26/2008 | US20080153891 Synergistic anti-cancer compositions |
| 06/26/2008 | US20080153883 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 06/26/2008 | US20080153877 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 06/26/2008 | US20080153875 Novel indole derivatives and their use as medicament |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153867 Alzheimer's disease, cognitive disorders, memory disorders, dementia, attention deficit disorder, traumatic brain injury, drug dependence, addiction; -chloro-N-{[3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazolyl]-[7-(1,2,3,4-tetrahydroacridin-9-ylamino)heptylamino]methylene}benzene-sulfonamide |
| 06/26/2008 | US20080153865 Water soluble paclitaxel derivatives |
| 06/26/2008 | US20080153854 Novel fused heterocycles and uses thereof |
| 06/26/2008 | US20080153853 Use of mtki 1 for treating or preventing brain cancer |
| 06/26/2008 | US20080153844 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 06/26/2008 | US20080153842 Synergistic mixture of a thiazolecarboxamide derivative, especially N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, and an antiproliferative cytotoxic agent such as paclitaxel, procarbazine, mitoxantrone or an epidophyllotoxin |
| 06/26/2008 | US20080153838 Compounds Having Tie2 (Tek) Activity |
| 06/26/2008 | US20080153837 4-(Benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene derivatives; treating disorders related to Hsp90 protein; anticarcinogenic, antimetastasis, antitumor, anticoagulant, antiproliferative, antihistamine, and antidiabetic agents; metabolic, muscular, rheumatic and nervous system disorders |
| 06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 06/26/2008 | US20080153833 Substituted pteridines for the treatment of inflammatory diseases |
| 06/26/2008 | US20080153815 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 06/26/2008 | US20080153812 Novel compounds |
| 06/26/2008 | US20080153791 Administering (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,;14bR)-10-(2-Carboxy-phenoxy)-2,4a,6a,;6b,9,9,12a-heptamethyl-13-oxo-1,2,;3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,;12a,12b,13,14b-icosahydro-picene-2-;carboxylic acid methyl ester; metabolic diseases, cancer, cell proliferation, glaucoma, |
| 06/26/2008 | US20080153768 Treatment of neurological disorders by dsrna administration |
| 06/26/2008 | US20080153765 Inducing apoptosis in a bcl-6-expressing cell or a non-Hodgkin's lymphoma cell; nucleic acid molecule having a sequence corresponding to or complementary to accessible regions of bcl-6 mRNA, vectors, cells, |
| 06/26/2008 | US20080153755 Antitumor peptide; risk of adverse immune reactions such as anaphylactic shock is greatly diminished |
| 06/26/2008 | US20080153754 Phenotypic reversion of pancreatic carcinoma cells |
| 06/26/2008 | US20080153752 artificial polypeptides as inhibitor of hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparin, keratan sulfate, keratosulfate, chitin, chitosan 1, and chitosan 2; for treatment of inflammatory diseases, tumor, cancer, cancer metastasis, and autoimmune diseases |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153750 Fermenting an appropriate microorganism using glucose as a carbon source and separating by chromatography, has a purity of at least 98%; specific binding or targeting to transferrin; use in the treatment of CNS neoplasm; antitumor agents |
| 06/26/2008 | US20080153746 Diagnosis and Treatment of Myeloid and Lymphoid Cell Cancers |